Skip to main content

Advertisement

SpringerLink
Log in

Primary nervous system lymphoma

  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Primary nervous system lymphoma (PNSL) is a rare type of non-Hodgkin’s lymphoma confined to the nervous system. Although significant progress has been made in the treatment of PNSL over the past decade, patients with this disease are rarely cured. Until recently, whole brain radiation therapy has been the standard treatment for PNSL. However, whole brain radiation therapy is associated with a high relapse rate and late neurotoxicity after chemotherapy, especially in patients older than 60 years of age. Methotrexate-based chemotherapy has become the standard approach to treat patients with newly diagnosed PNSL. Ongoing research efforts are focused on identifying chemotherapeutic agents with good antilymphoma activity that penetrate the blood-brain barrier. The roles of intrathecal chemotherapy and blood-brain barrier disruption are not fully defined. Given the rarity of this tumor, patients with PNSL should be referred to tertiary cancer centers where ongoing clinical trials are underway to identify the optimal treatment of PNSL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Central Brain Tumor Registry of the United States: Year 2001 annual statistics report: brain tumors in the U.S. 1992-1997. http://cbtrus.org/2001/ 2001stats_report.htm.

  2. Schabet M: Epidemiology of primary CNS lymphoma. J Neurooncol 1999, 43:199–201.

    Article  PubMed  CAS  Google Scholar 

  3. Eby NL, Grufferman S, Flannelly CM, et al.: Increasing incidence of primary brain lymphoma in the U.S. Cancer 1988, 62:2461–2465.

    Article  PubMed  CAS  Google Scholar 

  4. Henry JM, Heffner RR Jr, Dillard SH, et al.: Primary malignant lymphomas of the central nervous system. Cancer 1974, 34:1293–1302.

    Article  PubMed  CAS  Google Scholar 

  5. Loeffler JS, Ervin TJ, Mauch P, et al.: Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol 1985, 3:490–494. This review provides important data on the patterns of failure in patients with PNSL who were largely treated with WBRT.

    PubMed  CAS  Google Scholar 

  6. Uematsu M, Kondo M, Dokiya T, et al.: Primary non-AIDS related brain lymphoma: patterns of failure following radiotherapy. Acta Oncol 1992, 31:551–554.

    PubMed  CAS  Google Scholar 

  7. Nelson DF, Martz KL, Bonner H, et al.: Non-Hodgkin’s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992, 23:9–17. This prospective phase II study by the Radiation Therapy Oncology Group is the definitive study of WBRT alone in patients with PNSL.

    PubMed  CAS  Google Scholar 

  8. O’Neill BP, Wang CH, O’Fallon JR, et al.: Primary central nervous system non-Hodgkin’s lymphoma (PCNSL): survival advantages with combined initial therapy? A final report of the North Central Cancer Treatment Group (NCCTG) Study 86-72-52. Int J Radiat Oncol Biol Phys 1999, 43:559–563.

    Article  PubMed  CAS  Google Scholar 

  9. Schultz C, Scott C, Sherman W, et al.: Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of the Radiation Therapy Oncology Group Protocol 88-06. J Clin Oncol 1996, 14:556–564.

    PubMed  CAS  Google Scholar 

  10. DeAngelis LM, Yahalom J, Thaler HT, et al.: Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992, 10:635–643.

    PubMed  CAS  Google Scholar 

  11. Abrey LE, DeAngelis LM, Yahalom J: Long-term survival in primary CNS lymphoma. J Clin Oncol 1998, 16:859–863.

    PubMed  CAS  Google Scholar 

  12. Abrey LE, Yahalom J, DeAngelis LM: Treatment for primary CNS lymphoma: the next step. J Clin Oncol 2000, 18:3144–3150. This study is a comprehensive report on the efficacy and safety of methotrexate-based chemotherapy and WBRT (“combined modality therapy”).

    PubMed  CAS  Google Scholar 

  13. Abrey LE, Yahalom J, DeAngelis LM: Relapse and late neurotoxicity in primary central nervous system lymphoma (PCNSL) [abstract]. Neurology 1997, 48:A18.

    Google Scholar 

  14. Guha-Thakurta N, Damek D, Pollack C, et al.: Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients. J Neurooncol 1999, 43:259–268. This study describes the clinical response to methotrexate alone and the quality of life in patients with PNSL.

    Article  PubMed  CAS  Google Scholar 

  15. Batchelor TT, Hochberg FH, O’Neill A, et al.: The treatment of primary central nervous system lymphoma (PCNSL) with methotrexate and deferred radiotherapy: NABTT 96-07 [abstract]. Proc ASCO 2000, 19:159a.

    Google Scholar 

  16. Ng S, Rosenthal MA, Ashley D, et al.: High-dose methotrexate for primary CNS lymphoma in the elderly. Neuro-oncology 2000, 2:40–44.

    Article  PubMed  CAS  Google Scholar 

  17. Herrlinger U, Schabet M, Brugger W, et al.: German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma. Ann Neurol 2002, 51:247–252.

    Article  PubMed  CAS  Google Scholar 

  18. Ferreri AJ, Reni M, Pasini F, et al.: A multicenter study of treatment of primary CNS lymphoma. Neurology 2002, 58:1513–1520.

    PubMed  CAS  Google Scholar 

  19. McAllister LD, Doolittle ND, Guastadisegni PE, et al.: Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma. Neurosurgery 2000, 46:51–60. This study summarizes the utility of blood-brain barrier disruption followed by methotrexate with a particular emphasis on long-term cognitive effects of this therapy.

    Article  PubMed  CAS  Google Scholar 

  20. Soussain C, Hoang-Xuan K, Azar N, et al.: Pilot study of intensive chemotherapy followed by hematopoietic stem cells rescue (IC+HCR) in patients with refractory or relapsed primary central nervous system lymphoma (PCNSL) or intraocular lymphoma (IOL) [abstract]. Neurology 1999, 52:A246-A247.

    Google Scholar 

  21. Reni M, Ferreri AJ, Villa E: Second-line treatment for primary central nervous system lymphoma. Br J Cancer 1999, 79:530–534.

    Article  PubMed  CAS  Google Scholar 

  22. Sharis CM, Hochberg FH, Thornton AF, Loeffler JS: Is there a role for cranial radiotherapy after primary high dose intravenous methotrexate in primary central nervous system lymphoma [abstract]? Int J Radiat Oncol Biol Phys 1999, 45:327.

    Article  Google Scholar 

  23. Hochberg FH, Miller DC: Primary central nervous system lymphoma. J Neurosurg 1988, 68:835–853.

    PubMed  CAS  Google Scholar 

  24. Margolis L, Fraser R, Lichter A, et al.: The role of radiation therapy in the management of ocular reticulum cell sarcoma. Cancer 1980, 45:688–692.

    Article  PubMed  CAS  Google Scholar 

  25. Fishburne BC, Wilson DJ, Rosenbaum JT, et al.: Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol 1997, 115:1152–1156.

    PubMed  CAS  Google Scholar 

  26. Baumann MA, Ritch PS, Hande KR, et al.: Treatment of intraocular lymphoma with high-dose Ara-C. Cancer 1986, 57:1273–1275.

    Article  PubMed  CAS  Google Scholar 

  27. Strauchen JA, Dalton J, Friedman AH: Chemotherapy in the management of intraocular lymphoma. Cancer 1989, 63:1918–1921.

    Article  PubMed  CAS  Google Scholar 

  28. Sandor V, Stark-Vancs V, Pearson D, et al.: Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol 1998, 16:3000–3006.

    PubMed  CAS  Google Scholar 

  29. Henson JW, Yang J, Batchelor TT: Intraocular methotrexate level after high-dose intravenous infusion. J Clin Oncol 1998, 17:1329.

    Google Scholar 

  30. Baumgartner JE, Rachlin JR, Beckstead JH, et al.: Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990, 73:206–211.

    Article  PubMed  CAS  Google Scholar 

  31. Chamberlain MC, Kormanik PA: AIDS-related central nervous system lymphomas. J Neurooncol 1999, 43:269–276.

    Article  PubMed  CAS  Google Scholar 

  32. Ling SM, Roach M, Larson DA, et al.: Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus: ten years of treatment experience at the University of California-San Francisco. Cancer 1994, 73:2570–2582.

    Article  PubMed  CAS  Google Scholar 

  33. Formenti SC, Gill PS, Lean E, et al.: Primary central nervous system lymphoma in AIDS: results of radiation therapy. Cancer 1989, 63:1101–1107.

    Article  PubMed  CAS  Google Scholar 

  34. Kaufmann T, Nisce LZ, Coleman M: A comparison of survival of patients treated for AIDS-related central nervous system lymphoma with and without tissue diagnosis. Int J Radiat Oncol Biol Phys 1996, 36:429–432.

    Article  PubMed  CAS  Google Scholar 

  35. Antinori A, De Rossi G, Ammassari A, et al.: Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma. J Clin Oncol 1999, 17:554–560.

    PubMed  CAS  Google Scholar 

  36. Forsyth PA, Yahalom J, DeAngelis LM: Combinedmodality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology 1994, 44:1473–1479.

    PubMed  CAS  Google Scholar 

  37. Jacomet C, Girard PM, Lebrette MG, et al.: Intravenous methotrexate for primary central nervous system non-Hodgkin’s lymphoma in AIDS. AIDS 1997, 11:1725–1730.

    Article  PubMed  CAS  Google Scholar 

  38. Raez L, Cabral L, Cai JP, et al.: Treatment of AIDSrelated primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2. AIDS Res Hum Retroviruses 1999, 15:713–719.

    Article  PubMed  CAS  Google Scholar 

  39. O’Neill BP, O’Fallon JR, Earle JD, et al.: Primary central nervous system non-Hodgkin’s lymphoma: survival advantages with combined initial therapy? Int J Radiat Oncol Biol Phys 1995, 33:663–673.

    Article  PubMed  CAS  Google Scholar 

  40. Glass J, Gruber ML, Cher L, et al.: Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 1994, 81:188–195.

    PubMed  CAS  Google Scholar 

  41. O’Brien P, Roos D, Pratt G, et al.: Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol 2000, 18:519–526.

    PubMed  CAS  Google Scholar 

  42. Brada M, Hjiyiannakis D, Hines F, et al.: Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma (PCL). Int J Radiat Oncol Biol Phys 1998, 40:1157–1162.

    Article  PubMed  CAS  Google Scholar 

  43. DeAngelis LM, Seiferheld W, Schold SC, et al.: Combined modality treatment of primary central nervous system lymphoma (PCNSL): RTOG 93-10 [abstract]. Proc ASCO 2000, 19:140a.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Brain Tumor Center, Cox 315, Massachusetts General Hospital, 100 Blossom Street, 02114, Boston, MA, USA

    Scott R. Plotkin MD, PhD & Tracy T. Batchelor MD, MPH

Authors
  1. Scott R. Plotkin MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tracy T. Batchelor MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Plotkin, S.R., Batchelor, T.T. Primary nervous system lymphoma. Curr. Treat. Options in Oncol. 3, 525–535 (2002). https://doi.org/10.1007/s11864-002-0071-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-002-0071-7

Keywords

Search

Navigation